Suppr超能文献

野生型和α(2A/D) -肾上腺素能受体基因敲除小鼠输精管中接头后α1 -和α2 -肾上腺素能受体亚型的研究

Investigation of postjunctional alpha1- and alpha2-adrenoceptor subtypes in vas deferens from wild-type and alpha(2A/D)-adrenoceptor knockout mice.

作者信息

Cleary Linda, Vandeputte Catherine, Docherty James R

机构信息

Department of Physiology, Royal College of Surgeons in Ireland, 123 St Stephen's Green, Dublin 2, Ireland.

出版信息

Br J Pharmacol. 2003 Mar;138(6):1069-76. doi: 10.1038/sj.bjp.0705137.

Abstract
  1. The subtypes of alpha(1)- and alpha(2)-adrenoceptor mediating contractions of vas deferens have been examined in wild-type and alpha(2A/D)-adrenoceptor knockout mice. 2. Maximum contractions to noradrenaline but not phenylephrine were significantly greater in vas from wild-type. The alpha(1A)-adrenoceptor antagonist RS100329 (5-methyl-3-[3-[4-[2-(2,2,2,-trifluoroethoxy)phenyl]-1-piperazinyl]propyl]-2,4-(1H)-pyrimidinedione) (10 nM) significantly shifted the potency of noradrenaline. The alpha(2D)-adrenoceptor antagonist BRL 44408 (2-[(4,5-dihydro-1H-imidazol-2-yl)methyl]-2,3-dihydro-1-methyl-1H-isoindole) significantly reduced the maximum contraction to noradrenaline in wild-type but not in knockout. 3. Following prazosin (0.1 micro M), a component of the contraction to noradrenaline in wild-type but not in knockout was sensitive to the alpha(2)-adrenoceptor antagonist yohimbine. 4. Nifedipine (10 micro M) or suramin (100 micro M) reduced the contraction to 10 Hz stimulation for 4 s to an early peak and small maintained response. The peak was abolished by the alpha(1)-adrenoceptor antagonist prazosin. 5. RS100329 or prazosin inhibited 10 Hz stimulation evoked contractions with a U-shaped concentration-response curve: inhibiting responses up to 0.1 micro M, with a reversal of inhibition above this concentration. In the presence of suramin or nifedipine, the reversal of inhibition by high concentrations of prazosin was reduced. 6. The alpha(1D)-adrenoceptor selective antagonist BMY7378 (8-[2-(4-(2- methoxyphenyl)piperazin-1-yl)ethyl]-8-azaspiro[4,5]decane-7,9-dione) produced inhibition of 10 Hz evoked contractions only in high concentrations. 7. In conclusion, contractions to nerve stimulation in mouse vas deferens involve largely alpha(1A)-adrenoceptors and purinoceptors. alpha(1)-Adrenoceptor antagonists in high concentrations increase the purinergic response presumably by blocking prejunctional alpha(2)-adrenoceptor-mediated inhibition. In the presence of nifedipine, responses are predominantly alpha(1)-adrenoceptor mediated. Contractions to exogenous noradrenaline involved both alpha(1A)- and alpha(2A/D)-adrenoceptors in wild-type mice.
摘要
  1. 已在野生型和α(2A/D)-肾上腺素能受体基因敲除小鼠中研究了介导输精管收缩的α(1)-和α(2)-肾上腺素能受体亚型。2. 野生型输精管对去甲肾上腺素而非苯肾上腺素的最大收缩反应明显更强。α(1A)-肾上腺素能受体拮抗剂RS100329(5-甲基-3-[3-[4-[2-(2,2,2-三氟乙氧基)phenyl]-1-哌嗪基]丙基]-2,4-(1H)-嘧啶二酮)(10 nM)显著改变了去甲肾上腺素的效价。α(2D)-肾上腺素能受体拮抗剂BRL 44408(2-[(4,5-二氢-1H-咪唑-2-基)甲基]-2,3-二氢-1-甲基-1H-异吲哚)显著降低了野生型而非基因敲除小鼠对去甲肾上腺素的最大收缩反应。3. 给予哌唑嗪(0.1 μM)后,野生型而非基因敲除小鼠中对去甲肾上腺素收缩反应的一部分对α(2)-肾上腺素能受体拮抗剂育亨宾敏感。4. 硝苯地平(10 μM)或苏拉明(100 μM)将对10 Hz刺激4 s的收缩反应降低至早期峰值和较小的持续反应。该峰值被α(1)-肾上腺素能受体拮抗剂哌唑嗪消除。5. RS100329或哌唑嗪以U形浓度-反应曲线抑制10 Hz刺激诱发的收缩:在0.1 μM以下浓度抑制反应,在此浓度以上抑制作用逆转。在存在苏拉明或硝苯地平的情况下,高浓度哌唑嗪的抑制作用逆转减弱。6. α(1D)-肾上腺素能受体选择性拮抗剂BMY7378(8-[2-(4-(2-甲氧基苯基)哌嗪-1-基)乙基]-8-氮杂螺[4,5]癸烷-7,9-二酮)仅在高浓度时才抑制10 Hz诱发的收缩。7. 总之,小鼠输精管对神经刺激的收缩主要涉及α(1A)-肾上腺素能受体和嘌呤受体。高浓度的α(1)-肾上腺素能受体拮抗剂可能通过阻断突触前α(2)-肾上腺素能受体介导的抑制作用来增强嘌呤能反应。在存在硝苯地平的情况下,反应主要由α(1)-肾上腺素能受体介导。野生型小鼠对外源性去甲肾上腺素的收缩反应涉及α(1A)-和α(2A/D)-肾上腺素能受体。

相似文献

引用本文的文献

5
Physiological and pharmacological aspects of the vas deferens-an update.输精管的生理和药理学方面的研究进展。
Front Pharmacol. 2013 Aug 22;4:101. doi: 10.3389/fphar.2013.00101. eCollection 2013.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验